Innate immunity in solid organ transplantation: an update and therapeutic opportunities

References

• Sayegh MH. Why do we reject a graft? Role of indirect allorecognition in graft rejection. Kidney Int 1999;56(5):1967-79
   Google Scholar
• Oberbarnscheidt MH, Zeng Q, Li Q, et al. Non-self recognition by monocytes initiates allograft rejection. J Clin Invest 2014;124(8):3579-89
   PubMed Web of Science ®Google Scholar
• Stegall MD, Diwan T, Raghavaiah S, et al. Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant 2011;11(11):2405-13
   PubMed Web of Science ®Google Scholar
• Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005;5(12):953-64
   PubMed Web of Science ®Google Scholar
• Tinckam KJ, Djurdjev O, Magil AB. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int 2005;68(4):1866-74
   Google Scholar
• Hoffmann SC, Hale DA, Kleiner DE, et al. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005;5(3):573-81
   Google Scholar
• Grandaliano G, Gesualdo L, Ranieri E, et al. Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection. Transplantation 1997;63(3):414-20
   PubMed Web of Science ®Google Scholar
• Ozdemir BH, Ozdemir FN, Gungen Y, et al. Role of macrophages and lymphocytes in the induction of neovascularization in renal allograft rejection. Am J Kidney Dis 2002;39(2):347-53
   Google Scholar
• Kirk AD, Hale DA, Mannon RB, et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 2003;76(1):120-9
   PubMed Web of Science ®Google Scholar
• De Serres SA, Vadivel N, Mfarrej BG, et al. Monocyte-secreted inflammatory cytokines are associated with transplant glomerulopathy in renal allograft recipients. Transplantation 2011;91(5):552-9
   Google Scholar
• De Serres SA, Mfarrej BG, Grafals M, et al. Derivation and validation of a cytokine-based assay to screen for acute rejection in renal transplant recipients. Clin J Am Soc Nephrol 2012;7(6):1018-25
   PubMed Web of Science ®Google Scholar
• Papadimitriou JC, Drachenberg CB, Munivenkatappa R, et al. Glomerular inflammation in renal allografts biopsies after the first year: cell types and relationship with antibody-mediated rejection and graft outcome. Transplantation 2010;90(12):1478-85
   Google Scholar
• Magil AB, Tinckam K. Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int 2003;63(5):1888-93
   Google Scholar
• Batal I, De Serres SA, Mfarrej BG, et al. Glomerular Inflammation Correlates With Endothelial Injury and With IL-6 and IL-1beta Secretion in the Peripheral Blood. Transplantation 2014;97(10):1034-42
   Google Scholar
• Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest 2008;118(11):3522-30
   PubMed Web of Science ®Google Scholar
• Nathan CF. Secretory products of macrophages. J Clin Invest 1987;79(2):319-26
   PubMed Web of Science ®Google Scholar
• Haniffa M, Ginhoux F, Wang XN, et al. Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation. J Exp Med 2009;206(2):371-85
   Google Scholar
• Kwan T, Wu H, Chadban SJ. Macrophages in renal transplantation: Roles and therapeutic implications. Cell Immunol 2014;291(1-2):58-64
   Google Scholar
• Ma FY, Woodman N, Mulley WR, et al. Macrophages contribute to cellular but not humoral mechanisms of acute rejection in rat renal allografts. Transplantation 2013;96(11):949-57
   Google Scholar
• Lechler R, Ng WF, Steinman RM. Dendritic cells in transplantation--friend or foe? Immunity 2001;14(4):357-68
   Google Scholar
• Liu W, Li XC. An overview on non-T cell pathways in transplant rejection and tolerance. Curr Opin Organ Transplant 2010;15(4):422-6
   Google Scholar
• Jurewicz M, Takakura A, Augello A, et al. Ischemic injury enhances dendritic cell immunogenicity via TLR4 and NF-kappa B activation. J Immunol 2010;184(6):2939-48
   Google Scholar
• Ojo AO. Expanded criteria donors: process and outcomes. Semin Dial 2005;18(6):463-8
   Google Scholar
• Chamorro S, Garcia-Vallejo JJ, Unger WW, et al. TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program. J Immunol 2009;183(5):2984-94
   Google Scholar
• Thomson AW. Tolerogenic dendritic cells: all present and correct? Am J Transplant 2010;10(2):214-19
   Google Scholar
• Darrasse-Jeze G, Deroubaix S, Mouquet H, et al. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J Exp Med 2009;206(9):1853-62
   PubMed Web of Science ®Google Scholar
• Chen W, Liang X, Peterson AJ, et al. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J Immunol 2008;181(8):5396-404
   PubMed Web of Science ®Google Scholar
• Ezzelarab MB, Zahorchak AF, Lu L, et al. Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates. Am J Transplant 2013;13(8):1989-2005
   Google Scholar
• Khan A, Fu H, Tan LA, et al. Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition. Eur J Immunol 2013;43(3):734-46
   Google Scholar
• Turnquist HR, Raimondi G, Zahorchak AF, et al. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J Immunol 2007;178(11):7018-31
   PubMed Web of Science ®Google Scholar
• Giannoukakis N, Phillips B, Finegold D, et al. Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 2011;34(9):2026-32
   PubMed Web of Science ®Google Scholar
• Villard J. The role of natural killer cells in human solid organ and tissue transplantation. J Innate Immun 2011;3(4):395-402
   Google Scholar
• Kroemer A, Edtinger K, Li XC. The innate natural killer cells in transplant rejection and tolerance induction. Curr Opin Organ Transplant 2008;13(4):339-43
   PubMed Web of Science ®Google Scholar
• Campbell KS, Purdy AK. Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations. Immunology 2011;132(3):315-25
   PubMed Web of Science ®Google Scholar
• Liu W, Xiao X, Demirci G, et al. Innate NK cells and macrophages recognize and reject allogeneic nonself in vivo via different mechanisms. J Immunol 2012;188(6):2703-11
   Google Scholar
• Kitchens WH, Uehara S, Chase CM, et al. The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 2006;81(6):811-17
   Google Scholar
• Luan FL, Steffick DE, Gadegbeku C, et al. Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression. Am J Transplant 2009;9(1):160-8
   Google Scholar
• Yu G, Xu X, Vu MD, et al. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006;203(8):1851-8
   Web of Science ®Google Scholar
• Kroemer A, Xiao X, Degauque N, et al. The innate NK cells, allograft rejection, and a key role for IL-15. J Immunol 2008;180(12):7818-26
   Google Scholar
• Ghobrial RM, Freise CE, Trotter JF, et al. Donor morbidity after living donation for liver transplantation. Gastroenterology 2008;135(2):468-76
   PubMed Web of Science ®Google Scholar
• Fisher MA, Taylor GW, Shelton BJ, et al. Periodontal disease and other nontraditional risk factors for CKD. Am J Kidney Dis 2008;51(1):45-52
   Google Scholar
• Luan FL, Miles CD, Cibrik DM, et al. Impact of simultaneous pancreas and kidney transplantation on cardiovascular risk factors in patients with type 1 diabetes mellitus. Transplantation 2007;84(4):541-4
   Google Scholar
• Vasconcellos LM, Schachter AD, Zheng XX, et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998;66(5):562-6
   Google Scholar
• Beilke JN, Kuhl NR, Van Kaer L, et al. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med 2005;11(10):1059-65
   Google Scholar
• Lovik G, Vaage JT, Dissen E, et al. Characterization and molecular cloning of rat C1qRp, a receptor on NK cells. Eur J Immunol 2000;30(12):3355-62
   Google Scholar
• Baldwin WM3rd, Larsen CP, Fairchild RL. Innate immune responses to transplants: a significant variable with cadaver donors. Immunity 2001;14(4):369-76
   Google Scholar
• Shao-Hsien C, Lang I, Gunn H, et al. Effect of in vitro cyclosporin. A treatment on human natural and antibody-dependent cell-mediated cytotoxicity. Transplantation 1983;35(2):127-9
   Google Scholar
• Wasik M, Gorski A, Stepien-Sopniewska B, et al. Effect of FK506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro. Transplantation 1991;51(1):268-70
   PubMedGoogle Scholar
• Kageyama S, Matsui S, Hasegawa T, et al. Augmentation of natural killer cell activity induced by cytomegalovirus infection in mice treated with FK506. Acta Virol 1997;41(4):215-20
   Google Scholar
• Mocsai A. Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J Exp Med 2013;210(7):1283-99
   PubMed Web of Science ®Google Scholar
• Kreisel D, Nava RG, Li W, et al. In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation. Proc Natl Acad Sci USA 2010;107(42):18073-8
   Google Scholar
• Potter NS, Harding CV. Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes. J Immunol 2001;167(5):2538-46
   Google Scholar
• Megiovanni AM, Sanchez F, Robledo-Sarmiento M, et al. Polymorphonuclear neutrophils deliver activation signals and antigenic molecules to dendritic cells: a new link between leukocytes upstream of T lymphocytes. J Leukoc Biol 2006;79(5):977-88
   Google Scholar
• Kreisel D, Sugimoto S, Zhu J, et al. Emergency granulopoiesis promotes neutrophil-dendritic cell encounters that prevent mouse lung allograft acceptance. Blood 2011;118(23):6172-82
   PubMedGoogle Scholar
• Yamamoto S, Nava RG, Zhu J, et al. Cutting edge: pseudomonas aeruginosa abolishes established lung transplant tolerance by stimulating B7 expression on neutrophils. J Immunol 2012;189(9):4221-5
   Google Scholar
• Ojo AO. Renal disease in recipients of nonrenal solid organ transplantation. Semin Nephrol 2007;27(4):498-507
   PubMed Web of Science ®Google Scholar
• Hirayama S, Shiraishi T, Shirakusa T, et al. Prevention of neutrophil migration ameliorates rat lung allograft rejection. Mol Med 2006;12(9-10):208-13
   Google Scholar
• Fukono Y, Hayashi S, Kosha K, et al. Chemokine receptor inhibitor, Antileukinate, suppressed ovalbumin-induced eosinophilic inflammation in the airway. Cytokine 2003;22(5):116-25
   Google Scholar
• Hayashi S, Yatsunami J, Fukono Y, et al. Antileukinate, a hexapeptide inhibitor of CXC-chemokine receptor, supresses bleomycin-induced actute lung injury in mice. Lung 2002;180(6):339-48
   Google Scholar
• El-Sawy T, Belperio JA, Strieter RM, et al. Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection. Circulation 2005;112(3):320-31
   Google Scholar
• Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. Saunders Elsevier; Philadelphia: 2007
   Google Scholar
• Leventhal JS, Schroppel B. Toll-like receptors in transplantation: sensing and reacting to injury. Kidney Int 2012;81(9):826-32
   PubMed Web of Science ®Google Scholar
• Chen L, Wang T, Zhou P, et al. TLR engagement prevents transplantation tolerance. Am J Transplant 2006;6(10):2282-91
   PubMed Web of Science ®Google Scholar
• Testro AG, Visvanathan K, Skinner N, et al. Acute allograft rejection in human liver transplant recipients is associated with signaling through toll-like receptor 4. J Gastroenterol Hepatol 2011;26(1):155-63
   Google Scholar
• Ohashi K, Burkart V, Flohe S, et al. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000;164(2):558-61
   PubMed Web of Science ®Google Scholar
• He H, Stone JR, Perkins DL. Analysis of differential immune responses induced by innate and adaptive immunity following transplantation. Immunology 2003;109(2):185-96
   Google Scholar
• Tsan MF, Gao B. Heat shock proteins and immune system. J Leukoc Biol 2009;85(6):905-10
   PubMed Web of Science ®Google Scholar
• Goldstein DR, Tesar BM, Akira S, et al. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 2003;111(10):1571-8
   PubMed Web of Science ®Google Scholar
• Wu H, Noordmans GA, O’Brien MR, et al. Absence of MyD88 signaling induces donor-specific kidney allograft tolerance. J Am Soc Nephrol 2012;23(10):1701-16
   Google Scholar
• Zhang N, Kruger B, Lal G, et al. Inhibition of TLR4 signaling prolongs Treg-dependent murine islet allograft survival. Immunol Lett 2010;127(2):119-25
   Google Scholar
• Lal G, Yin N, Xu J, et al. Distinct inflammatory signals have physiologically divergent effects on epigenetic regulation of Foxp3 expression and Treg function. Am J Transplant 2011;11(2):203-14
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010;11(5):373-84
   PubMed Web of Science ®Google Scholar
• Strom TB, Koulmanda M. Recently discovered T cell subsets cannot keep their commitments. J Am Soc Nephrol 2009;20(8):1677-80
   Google Scholar
• McKay D, Shigeoka A, Rubinstein M, et al. Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection. Eur J Immunol 2006;36(8):1994-2002
   Google Scholar
• Zhang X, Beduhn M, Zheng X, et al. Induction of alloimmune tolerance in heart transplantation through gene silencing of TLR adaptors. Am J Transplant 2012;12(10):2675-88
   Google Scholar
• Palmer SM, Burch LH, Davis RD, et al. The Role of Innate Immunity in Acute Allograft Rejection after Lung Transplantation. Am J Respir Crit Care Med 2003;168(628):632
   Google Scholar
• Ducloux D, Deschamps M, Yannaraki M, et al. Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 2005;67(6):2454-61
   PubMedGoogle Scholar
• Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function. Available from: https://clinicaltrials.gov/ct2/show/NCT01794663
   Google Scholar
• Wu H, Ma J, Wang P, et al. HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol 2010;21(11):1878-90
   PubMed Web of Science ®Google Scholar
• Huang Y, Yin H, Han J, et al. Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am J Transplant 2007;7(4):799-808
   Google Scholar
• Ochando JC, Chen SH. Myeloid-derived suppressor cells in transplantation and cancer. Immunol Res 2012;54(1-3):275-85
   PubMed Web of Science ®Google Scholar
• Lee CK, Christensen LL, Magee JC, et al. Pre-transplant risk factors for chronic renal dysfunction after pediatric heart transplantation: a 10-year national cohort study. J Heart Lung Transplant 2007;26(5):458-65
   Google Scholar
• Dugast AS, Haudebourg T, Coulon F, et al. Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J Immunol 2008;180(12):7898-906
   PubMed Web of Science ®Google Scholar
• Miles CD, Schaubel DE, Jia X, et al. Mortality experience in recipients undergoing repeat transplantation with expanded criteria donor and non-ECD deceased-donor kidneys. Am J Transplant 2007;7(5):1140-7
   Google Scholar
• Ricklin D, Hajishengallis G, Yang K, et al. Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010;11(9):785-97
   PubMed Web of Science ®Google Scholar
• Ricklin D, Lambris JD. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol 2013;190(8):3831-8
   PubMed Web of Science ®Google Scholar
• Sacks SH, Zhou W. The role of complement in the early immune response to transplantation. Nat Rev Immunol 2012;12(6):431-42
   PubMed Web of Science ®Google Scholar
• Moller-Kristensen M, Wang W, Ruseva M, et al. Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury. Scand J Immunol 2005;61(5):426-34
   PubMed Web of Science ®Google Scholar
• Foreman KE, Vaporciyan AA, Bonish BK, et al. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 1994;94(3):1147-55
   PubMed Web of Science ®Google Scholar
• Vieyra M, Leisman S, Raedler H, et al. Complement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection. Am J Pathol 2011;179(2):766-74
   Web of Science ®Google Scholar
• Kwan WH, van der Touw W, Paz-Artal E, et al. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J Exp Med 2013;210(2):257-68
   Google Scholar
• Loupy A, Lefaucheur C, Vernerey D, et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med 2013;369(13):1215-26
   PubMed Web of Science ®Google Scholar
• Tinckam KJ, Heeger PS. Transplantation: complementing donor-specific antibody testing. Nat Rev Nephrol 2013;9(12):713-14
   Google Scholar
• Freitas MC, Rebellato LM, Ozawa M, et al. The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes. Transplantation 2013;95(9):1113-19
   PubMed Web of Science ®Google Scholar
• Chen G, Sequeira F, Tyan DB. Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. Hum Immunol 2011;72(10):849-58
   PubMed Web of Science ®Google Scholar
• Yabu JM, Higgins JP, Chen G, et al. C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation. Transplantation 2010;91(3):342-7
   Google Scholar
• Sutherland SM, Chen G, Sequeira FA, et al. Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss. Pediatr Transplant 2011;16(1):12-17
   Google Scholar
• Hillmen P, Young NS, Schubert J, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006;355(12):1233-43
   PubMed Web of Science ®Google Scholar
• Locke JE, Magro CM, Singer AL, et al. The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection. Am J Transplant 2009;9(1):231-5
   Web of Science ®Google Scholar
• Chatelet V, Lobbedez T, Fremeaux-Bacchi V, et al. Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report. Transplant Proc 2010;42(10):4353-5
   Google Scholar
• Bentall A, Tyan DB, Sequeira F, et al. Antibody-mediated rejection despite inhibition of terminal complement. Transpl Int 2014;27(12):1235-43
   Google Scholar
• Lesage J, Noel R, Lapointe I, et al. Donor-Specific Antibodies, C4d and Their Relationship With the Prognosis of Transplant Glomerulopathy. Transplantation 2015;99(1):69-76
   Google Scholar
• Sapir-Pichhadze R, Curran SP, John R, et al. A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection. Kidney Int 2015;87(1):182-94
   Google Scholar
• Nelson PJ, Krensky AM. Chemokines, chemokine receptors, and allograft rejection. Immunity 2001;14(4):377-86
   Google Scholar
• de Menezes Neves PD, Machado JR, dos Reis MA, et al. Distinct expression of interleukin 17, tumor necrosis factor alpha, transforming growth factor beta, and forkhead box P3 in acute rejection after kidney transplantation. Ann Diagn Pathol 2013;17(1):75-9
   Google Scholar
• Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;77(8):1627-52
   PubMed Web of Science ®Google Scholar
• Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005;293(7):830-5
   PubMed Web of Science ®Google Scholar
• Pepper AR, Gala-Lopez B, Ziff O, et al. Current status of clinical islet transplantation. World J Transplant 2013;3(4):48-53
   Google Scholar
• Mertens M, Singh JA. Anakinra for rheumatoid arthritis: a systematic review. J Rheumatol 2009;36(6):1118-25
   PubMed Web of Science ®Google Scholar
• McCall M, Pawlick R, Kin T, et al. Anakinra potentiates the protective effects of etanercept in transplantation of marginal mass human islets in immunodeficient mice. Am J Transplant 2011;12(2):322-9
   Google Scholar
• Matsumoto S, Takita M, Chaussabel D, et al. Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1beta and TNF-alpha. Cell Transplant 2011;20(10):1641-7
   PubMed Web of Science ®Google Scholar
• Patriarca F, Sperotto A, Damiani D, et al. Infliximab treatment for steroid-refractory acute graft-versus-host disease. Haematologica 2004;89(11):1352-9
   Web of Science ®Google Scholar
• Zhao X, Boenisch O, Yeung M, et al. Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance. Am J Transplant 2012;12(1):90-101
   PubMed Web of Science ®Google Scholar
• Shen H, Goldstein DR. IL-6 and TNF-alpha synergistically inhibit allograft acceptance. J Am Soc Nephrol 2009;20(5):1032-40
   PubMed Web of Science ®Google Scholar
• Tocilizumab for Renal Graft Inflammation. Available from: https://clinicaltrials.gov/ct2/show/NCT02108600
   Google Scholar
• Mortensen DL, Walicke PA, Wang X, et al. Pharmacokinetics and pharmacodynamics of multiple weekly subcutaneous efalizumab doses in patients with plaque psoriasis. J Clin Pharmacol 2005;45(3):286-98
   Google Scholar
• Posselt AM, Bellin MD, Tavakol M, et al. Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. Am J Transplant 2010;10(8):1870-80
   PubMed Web of Science ®Google Scholar
• Yamakuchi M, Kirkiles-Smith NC, Ferlito M, et al. Antibody to human leukocyte antigen triggers endothelial exocytosis. Proc Natl Acad Sci USA 2007;104(4):1301-6
   Google Scholar
• Valenzuela NM, Hong L. Shen X-D, et al.Blockade of P-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo. Am J Transplant 2013;13(2):299-311
   Google Scholar
• Gaber AO, Mulgaonkar S, Kahan BD, et al. YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study. Clin Transplant 2011;25(4):523-33
   Google Scholar
• El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009;9(3):527-35
   PubMed Web of Science ®Google Scholar
• Hutchinson JA, Riquelme P, Sawitzki B, et al. Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J Immunol 2011;187(5):2072-8
   Google Scholar
• The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation (DUET). Available from: https://clinicaltrials.gov/ct2/show/NCT02013037
   Google Scholar
• Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney Transplantation (TAMARCIN). Available from: https://clinicaltrials.gov/ct2/show/NCT02113891
   Google Scholar